APA (7th ed.) Citation

LS, V., M, C., KT, S., JB, L., JF, S., M, S., . . . K, C. (2017). How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country. International journal of cancer, 141(12), 2410. https://doi.org/10.1002/ijc.30926

Chicago Style (17th ed.) Citation

LS, Velentzis, et al. "How Will Transitioning from Cytology to HPV Testing Change the Balance Between the Benefits and Harms of Cervical Cancer Screening? Estimates of the Impact on Cervical Cancer, Treatment Rates and Adverse Obstetric Outcomes in Australia, a High Vaccination Coverage Country." International Journal of Cancer 141, no. 12 (2017): 2410. https://doi.org/10.1002/ijc.30926.

MLA (9th ed.) Citation

LS, Velentzis, et al. "How Will Transitioning from Cytology to HPV Testing Change the Balance Between the Benefits and Harms of Cervical Cancer Screening? Estimates of the Impact on Cervical Cancer, Treatment Rates and Adverse Obstetric Outcomes in Australia, a High Vaccination Coverage Country." International Journal of Cancer, vol. 141, no. 12, 2017, p. 2410, https://doi.org/10.1002/ijc.30926.